Unidrug Innov.Pharma
Ticker > Company >

Unidrug Innov.Pharma share price

Unidrug Innovative Pharma Technologies Ltd.

SECTOR: Pharmaceuticals & Drugs  1348   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year-5.06%
3 Year3.66%
5 Year5.21%

Profit Growth

1 Year115.83%
3 Year161.98%
5 Year90.9%

ROE%

1 Year38.44%
3 Year22.57%
5 Year14.82%

ROCE %

1 Year40.13%
3 Year25.12%
5 Year18.81%

Debt/Equity

0.45037541295425

Price to Cash Flow

0

Interest Cover Ratio

15.5250080671184

CFO/PAT (5 Yr. Avg.)

1.36705966509111

 Strengths

  • Company has been maintaining healthy ROE of 22.5748040686307% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.1227348121605% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 15.5250080671184.
  • The company has an efficient Cash Conversion Cycle of 45.2564329078102 days.

 Limitations

  • The company has shown a poor revenue growth of 3.65955245412719% for the Past 3 years.
  • Company has negative cash flow from operations of -0.7203.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 29.03 27.71 26.23 32.5 30.86
Total Expenditure 27.89 26.62 25.32 29.9 25.93
Operating Profit 1.14 1.09 0.91 2.61 4.93
Other Income 0.16 0.14 0.27 0.07 0.16
Interest 0.95 0.71 0.61 0.23 0.31
Depreciation 0.14 0.26 0.23 0.18 0.28
Exceptional Items 0 0 0 -0.22 0
Profit Before Tax 0.21 0.26 0.34 2.05 4.5
Tax 0.07 0.08 0.11 0.55 1.28
Net Profit 0.14 0.18 0.23 1.49 3.22
Adjusted EPS (Rs.) 0.18 0.23 0.31 1.95 4.2

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 1.97 1.97 1.97 1.97 1.97
Total Reserves 3.01 3.19 3.31 4.8 8.02
Borrowings 1.54 1.11 0.78 0.6 0.96
Other N/C liabilities 0.6 0.58 0.73 0.52 0.54
Current liabilities 11.84 9.45 8.28 9.89 7.72
Total Liabilities 18.95 16.3 15.06 17.78 19.2
Assets
Net Block 2.69 2.74 2.87 2.67 3.01
Capital WIP 0 0 0 0 0.07
Intangible WIP 0 0 0 0 0
Investments 0.22 0.22 0.22 0 0
Loans & Advances 0.05 0.05 1.24 1.63 0.83
Other N/C Assets 0 0 0 0 0
Current Assets 15.99 13.28 10.73 13.48 15.29
Total Assets 18.95 16.3 15.06 17.78 19.2
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019
Profit from operations 2.05 4.5
Adjustment 1.25 0.54
Changes in Assets & Liabilities -0.88 -4.5
Tax Paid -0.23 -1.26
Operating Cash Flow 2.19 -0.72
Investing Cash Flow -0.59 -0.64
Financing Cash Flow -1.16 1.42
Net Cash Flow 0.44 0.06

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Unidrug Innov.Pharma
X